PharmaBoardroom

Five Norwegian Medtechs to Watch

Norway, known more for its expertise in oil and gas and marine biology than in health innovation, is home to increasing numbers of innovative medical…

Thomas Willemsen – SVP APAC, Takeda

In an exclusive and wide-ranging interview, Takeda APAC SVP Thomas Willemsen outlines his strategy for bringing the company’s specialty pharma…

Supporting Value-Based Purchasing in the US Through Changes in…

Michael Ciarametaro, VP for Research at the US National Pharmaceutical Council (NPC), outlines issues surrounding the outdated Medicaid Best Price…

Andrew Hexter – Vice President & General Manager Asia…

Andrew Hexter, VP and GM of Gilead Asia 5 (Hong Kong, Singapore, South Korea, Taiwan and Malaysia), shares the highlights of his past three years…

Global Pharma Execs Hail ‘Unprecedented’ Speed &…

During the fourth International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) COVID-19 media briefing, one thematic dominated:…

Pfizer’s Bourla & MSD’s Frazier: No Cutting…

Top global pharma executives involved in the development of COVID-19 vaccines have stated their commitment to not rushing the release of any potential…

Canada Pharma News Roundup September 2020

The latest news from Canadian pharma including deals for J&J’s and Novavax’s COVID-19 vaccines, an abrupt end to Canada’s participation in…

Joong Myung Cho – Chairman & CEO, CrystalGenomics,…

Joong Myung Cho of Korean biotech success story CrystalGenomics introduces the company’s unique drug discovery platform, key growth factors, highly…

Sandoz Bolsters its European Essential Medicine Manufacturing…

In the wake of the COVID-19 crisis and the subsequent strain placed on medicine supply chains in Europe, Sandoz – the generics arm of global giant…

Japanese Pharma’s Skyrocketing US Footprint

Following PharmaBoardroom’s recent interview with Ivan Cheung, chairman of Eisai’s US affiliate and president of Eisai’s global neurology…

Michael G. Kauffman – Founder & CEO, Karyopharm…

Karyopharm Therapeutics’ Dr Michael G. Kauffman outlines the genesis of the company he co-founded with his wife, the approval journey of key product…

China Pharma News Roundup September 2020

The latest from Chinese pharma, including a setback for CanSinoBIO’s Canadian COVID-19 vaccine trial, Bayer’s new Beijing manufacturing plant, and…

Tagged with